
26.46 Delayed Data As of May 27 | ![]() Today’s Change | 19.38 Today|||52-Week Range 74.10 | -29.96% Year-to-Date |
The 15 analysts offering 12-month price forecasts for Axsome Therapeutics Inc have a median target of 62.00, with a high estimate of 180.00 and a low estimate of 27.00. The median estimate represents a +134.32% increase from the last price of 26.46.
The current consensus among 15 polled investment analysts is to Buy stock in Axsome Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.